임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
38건 표시
- 1상모집 중단 (진행 중)· Healthy ParticipantsA Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Healthy ParticipantsA Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Solid MalignanciesModular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Solid TumorA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· CardiovascularA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Soft Tissue SarcomaStudy Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Solid TumorA Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Esophageal CancerOrgan-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Solid TumoursA Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Neurofibromatosis Type 1Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
리드: 아스트라제네카 · 협력: 머크(MSD)
- 1상모집 중단 (진행 중)· Non-Small Cell Lung Cancer (NSCLC)HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
협력: 아스트라제네카, 머크(MSD)
- 1상모집 중단 (진행 중)· Primary Central Nervous System LymphomaAcalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· B-cell Non Hodgkin LymphomaA Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced or Metastatic NSCLCPhase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Metastatic Breast CancerA Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Neurofibromatosis 1A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
리드: 아스트라제네카 · 협력: 머크(MSD)
- 1상모집 중단 (진행 중)· Breast CancerDS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
협력: 아스트라제네카, 머크(MSD)
- 1상모집 중단 (진행 중)· Breast Cancer MetastaticOlaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
협력: 아스트라제네카, 머크(MSD)
- 1상모집 중단 (진행 중)· Small Cell Lung Cancer Extensive StageRadiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Metastatic Non-Small Cell Lung Cancer (NSCLC)A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· ER+ HER2- Advanced Breast CancerStudy of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Recurrent Glioblastoma MultiformeA Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Hormone Receptor Positive Breast CancerFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Muscle Invasive Bladder CancerOpen-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Breast CancerAdjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Mantle Cell Lymphoma (MCL)A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Solid MalignanciesDurvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerAscending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Non Small Cell Lung CancerAZD9291 in Combination With Ascending Doses of Novel Therapeutics
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Solid TumorsStudy of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· TumorAZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
리드: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.